IRRAS Overview

  • Founded
  • 2012
  • Status
  • Public
  • Employees
  • 51
  • Stock Symbol
Stock Symbol
  • Investments
  • 3
  • Share Price
  • $0.64
  • (As of Friday Closing)

IRRAS General Information


IRRAS AB is a commercial-stage medical technology company. The company develops and sells medical equipment for the treatment of brain pathologies, including a device for drainage and monitoring of intracranial pressure. Its product IRRAflow CNS System combines an External Drainage System, an ICP Monitor, and an Occlusion Solution Mechanism into a single, integrated device. It is easy to operate and provides a safe and effective system for intracranial fluid evacuation. Its geographical segments are Germany, Europe (excluding Germany), United States, and Other countries.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Devices and Supplies
Stock Exchange
Primary Office
  • Vasagatan 16
  • 111 20 Stockholm
  • Sweden
+46 010-211 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IRRAS Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.64 $0.69 $0.57 - $1.23 $45.7M 66.3M 116K -$0.24

IRRAS Financials Summary

In Thousands,
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 27,371 49,734 64,353 78,900
Revenue 1,100 801 559 689
EBITDA (13,383) (12,929) (14,685) (15,068)
Net Income (15,777) (14,741) (15,980) (15,957)
Total Assets 19,431 25,483 17,005 22,838
Total Debt 1,246 487 647 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

IRRAS Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IRRAS‘s full profile, request access.

Request a free trial

IRRAS Executive Team (6)

Name Title Board Seat Contact Info
Will Martin President & Chief Executive Officer
Sabina Berlin Chief Financial Officer
Ulrich Borchert Director, Sales International
Christos Panotopoulos MD Co-Founder & Special Advisor and Member of the IRRAS Clinical Advisory Board
Kleanthis Xanthopoulos Ph.D Board Member & Chief Executive Officer
You’re viewing 5 of 6 executive team members. Get the full list »

IRRAS Board Members (2)

Name Representing Role Since
000000 0000000 IRRAS Chairman 000 0000
000000000 000000000000 00.0 Self Board Member & Chief Executive Officer 000 0000
To view IRRAS’s complete board members history, request access »

IRRAS Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IRRAS Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore IRRAS‘s full profile, request access.

Request a free trial

IRRAS Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 00000 0 07-May-2019 000000000000000000 00000 Monitoring Equipment 000000000 000000000000 00.0
0000000000 00000 0 07-May-2019 000000000 00000 00 00000 Buildings and Property
DermaPort 23-Apr-2019 Merger/Acquisition Outcome Management (Healthcare) 000000000 000000000000 00.0
To view IRRAS’s complete investments and acquisitions history, request access »

IRRAS Subsidiaries (1)

Company Name Industry Location Founded
0000000000 00000 0 Monitoring Equipment Tustin, CA 0000
To view IRRAS’s complete subsidiaries history, request access »